Dr Ventrapati Pradeep
Current Work Location
Medicover Cancer Institute, Plot No: 5, BRTS Rd, Chinna Gadhili, Arilova, Visakhapatnam, Andhra Pradesh 530040
Info
Dr. Ventrapati Pradeep is a highly experienced Senior Consultant Medical Oncologist who focuses on providing personalized and patient-friendly cancer care. He trained at leading institutes like AIIMS, New Delhi, and Tata Memorial Hospital, Mumbai.
He treats a wide range of cancers, including breast, lung, head and neck, gastrointestinal, gynecological, and blood cancers. His approach combines advanced treatments such as chemotherapy, targeted therapy, immunotherapy, and bone marrow transplantation. He aims to deliver accurate treatment plans that improve recovery and enhance his patients' quality of life.
Expertise & Treatments
Dr. Ventrapati Pradeep provides comprehensive, evidence-based cancer care with a focus on precision medicine and personalized treatment plans.
Cancer Specialties (Types of Cancers Treated)
- Breast Cancer Treatment - Early detection, systemic therapy, and advanced-stage management
- Lung & Esophageal Cancer (Thoracic Oncology) - Targeted and immunotherapy-based care
- Head & Neck Cancer Treatment - Oral, throat, and related cancers
- Brain Tumors (Neuro Oncology) - Management of primary and metastatic brain cancers
- Gynecological Cancers - Ovarian, cervical, and endometrial cancer treatment
- Gastrointestinal Cancers - Stomach, liver, colorectal, and pancreatic cancers
- Blood Cancers - Leukemia, lymphoma, and myeloma
Advanced Cancer Treatments
- Chemotherapy - Standard and advanced drug-based cancer treatment
- Targeted Therapy - Precision medicine based on tumor genetics
- Immunotherapy - Boosting the immune system to fight cancer
- CAR T-Cell Therapy - Advanced cellular therapy for specific cancers
Dr. Pradeep has strong experience in both clinical practice and academic oncology. He has worked as an Assistant Professor at well-known institutions like Homi Bhabha Cancer Hospital and Tata Memorial Hospital.
He has contributed to clinical research, medical education, and ethical patient care through his involvement in research programs and institutional committees. He follows evidence-based treatment methods and keeps himself up to date with the latest developments in oncology. His expertise, dedication, and patient-focused approach make him a trusted specialist in cancer care.
Past Experience
Dr. Ventrapati Pradeep has gained extensive clinical and academic experience from some of India's leading cancer institutes, contributing to both patient care and oncology research.
- Ex Consultant Medical Oncologist - Apollo Cancer Centre, Vizag
- Assistant Professor (Medical Oncology) - Tata Memorial Hospital, Mumbai
- Assistant Professor (Medical Oncology) - Homi Bhabha Cancer Hospital & Research Centre, Visakhapatnam
- In-Charge, Clinical Research Secretariat - HBCH&RC, Visakhapatnam
- Clinician Member, Institutional Ethics Committee - HBCH&RC, Visakhapatnam
He has been actively involved in clinical research, academic training, and multidisciplinary cancer care, strengthening his expertise in delivering advanced and evidence-based oncology treatments.
Awards & Achievements
Dr. Ventrapati Pradeep has earned several recognitions throughout his academic and professional journey, reflecting his dedication to excellence in oncology and research.
- 2003 - Selected for the prestigious National Talent Search Examination (NTSE) Scholarship
- 2005 - Secured 49th rank in EAMCET, Andhra Pradesh
- 2013 - Achieved All India Rank 80 in AIIMS MD/MS Entrance Examination
- 2016 - Won 1st Prize in Head & Neck Oncology Quiz conducted by the Indian College of Radiation Oncology (ICRO)
- 2019 - Awarded 1st Prize at Mumbai Hematology Group Quarterly Conference for presentation on Acute Leukemia with FGFR Translocation
- 2020 - Presented Tata Memorial Hospital data on Young Breast Cancer at TAYCON 2020 and Women's Cancer Initiative (WCI) Conference
- 2020 - Authored a chapter on Chemotherapy-related Oral Complications and Management for a Dental Sciences textbook
- 2021 - Contributed a chapter on Role of PD-L1 in NSCLC and Other Solid Tumors for the TMH Evidence-Based Medicine (EBM) Book
These achievements highlight his strong academic foundation, research contributions, and commitment to advancing cancer care.
Memberships
Dr. Ventrapati Pradeep is an active member of leading oncology and medical organizations, reflecting his commitment to continuous learning and adherence to the highest standards in cancer care.
- Medical Council of India (MCI) / National Medical Commission (NMC)
- Indian Society of Medical & Paediatric Oncology (ISMPO)
- European Society for Medical Oncology (ESMO) (associated/academic participation)
- American Society of Clinical Oncology (ASCO) (academic engagement)
Through these professional memberships, he stays updated with the latest advancements, global guidelines, and research in oncology to provide the best possible care to his patients.
- Anaplastic hemangiopericytoma of eyelid: An unusual location
Published in Journal of Cancer Research and Therapeutics, 2017 Jan-Mar;13(1):145-147. - Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience
Published in Journal of Clinical Oncology, 2018; 36(4_suppl):857-857. - Pattern of microbial organisms in radiation-induced mucositis and dermatitis in head and neck squamous cell carcinoma (HNSCC) treated with RT/CTRT
Published in Journal of Clinical Oncology, 2014; 32(31_suppl):210-210. - A real-world data of immune checkpoint inhibitors in solid tumors from India
Authors include Noronha V, Abraham G, Patil V, Ventrapati P, et al.
Published in Cancer Medicine, 2021. - Real-World Outcomes With Generic Pomalidomide in Relapsed Refractory Multiple Myeloma-Experience From a Tertiary Care Cancer Center
Published in JCO Global Oncology, 2021; (7):361-367. - Adjuvant chemotherapy in stage II-III operated colon cancer patients from a non-trial cohort with predominant use of modified CAPOX
Published in South Asian Journal of Cancer, 2019 Jul;8(3):160-165. - A real-world data of immune checkpoint inhibitors in solid tumors from India
Published in Cancer Medicine, 2021;10(5):1525-1534. - Time for cancer to be designated a notifiable disease in India
Published in Cancer Research, Statistics, and Treatment, 2021;4(1):153. - Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India
Published in The Breast, 2021 Dec;60:177-184. - Old targets, new bullets, nursing fresh hope
Published in Cancer Research, Statistics, and Treatment, 2021 Oct;4(4):788.
His work reflects strong involvement in clinical research, oncology education, and scientific knowledge sharing at national platforms.
Book Oncologist Consultation
May 2026
Frequently Asked Questions
Dr. Ventrapati Pradeep is a Senior Consultant Medical Oncologist in Vizag, specializing in advanced cancer treatments such as chemotherapy, immunotherapy, and targeted therapy.
He treats a wide range of cancers including breast cancer, lung cancer, head & neck cancers, gastrointestinal cancers, gynecological cancers, and blood cancers like leukemia and lymphoma.
Dr. Pradeep provides chemotherapy, immunotherapy, targeted therapy, CAR T-cell therapy, and bone marrow/stem cell transplantation based on the patient's condition.
Yes, breast oncology is one of his key areas of expertise, including early detection and advanced-stage management.
Immunotherapy is a modern treatment that helps the body's immune system recognize and fight cancer cells more effectively.
You should consult a medical oncologist if you are diagnosed with cancer, need a second opinion, or are planning advanced treatments like chemotherapy or targeted therapy.
Yes, he specializes in treating hematological malignancies such as leukemia, lymphoma, and myeloma.
Yes, he is experienced in bone marrow and stem cell transplantation for eligible patients.
He practices in Vizag at leading cancer care centers, including Medicover Cancer Institute and Apollo Cancer Centre.
You can book an appointment by contacting the hospital directly via phone or through their official website.